

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.45704379 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 5.45704379 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.05418753 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 5.05418753 |
| 5 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.78032603 |
| 6 | alpha-linolenic acid metabolic process (GO:0036109) | 4.77289650 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 4.60688552 |
| 8 | low-density lipoprotein particle remodeling (GO:0034374) | 4.42087562 |
| 9 | negative regulation of cell killing (GO:0031342) | 4.37645230 |
| 10 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.37645230 |
| 11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.16601965 |
| 12 | bile acid biosynthetic process (GO:0006699) | 4.16397715 |
| 13 | reverse cholesterol transport (GO:0043691) | 4.12646155 |
| 14 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.09256281 |
| 15 | regulation of cholesterol esterification (GO:0010872) | 4.01894978 |
| 16 | tryptophan catabolic process (GO:0006569) | 3.88178122 |
| 17 | indole-containing compound catabolic process (GO:0042436) | 3.88178122 |
| 18 | indolalkylamine catabolic process (GO:0046218) | 3.88178122 |
| 19 | high-density lipoprotein particle remodeling (GO:0034375) | 3.82932169 |
| 20 | tryptophan metabolic process (GO:0006568) | 3.74008278 |
| 21 | protein-lipid complex remodeling (GO:0034368) | 3.73926572 |
| 22 | macromolecular complex remodeling (GO:0034367) | 3.73926572 |
| 23 | plasma lipoprotein particle remodeling (GO:0034369) | 3.73926572 |
| 24 | sulfur amino acid catabolic process (GO:0000098) | 3.69587556 |
| 25 | phospholipid efflux (GO:0033700) | 3.66969366 |
| 26 | complement activation, alternative pathway (GO:0006957) | 3.61073650 |
| 27 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.60540584 |
| 28 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.60540584 |
| 29 | glyoxylate metabolic process (GO:0046487) | 3.57421839 |
| 30 | complement activation, classical pathway (GO:0006958) | 3.55715627 |
| 31 | bile acid metabolic process (GO:0008206) | 3.53152316 |
| 32 | protein carboxylation (GO:0018214) | 3.52854188 |
| 33 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.52854188 |
| 34 | kynurenine metabolic process (GO:0070189) | 3.49960524 |
| 35 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.46326138 |
| 36 | regulation of triglyceride catabolic process (GO:0010896) | 3.41475647 |
| 37 | regulation of protein activation cascade (GO:2000257) | 3.41259480 |
| 38 | complement activation (GO:0006956) | 3.40823473 |
| 39 | plasma lipoprotein particle assembly (GO:0034377) | 3.40742227 |
| 40 | cysteine metabolic process (GO:0006534) | 3.36281118 |
| 41 | very long-chain fatty acid metabolic process (GO:0000038) | 3.35370417 |
| 42 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.34235205 |
| 43 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.29912598 |
| 44 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.29268110 |
| 45 | valine metabolic process (GO:0006573) | 3.29163980 |
| 46 | plasma lipoprotein particle organization (GO:0071827) | 3.25761885 |
| 47 | detection of other organism (GO:0098543) | 3.25422163 |
| 48 | regulation of cholesterol metabolic process (GO:0090181) | 3.24372042 |
| 49 | regulation of complement activation (GO:0030449) | 3.23977493 |
| 50 | tyrosine metabolic process (GO:0006570) | 3.21211198 |
| 51 | protein activation cascade (GO:0072376) | 3.20650561 |
| 52 | detection of bacterium (GO:0016045) | 3.17393615 |
| 53 | opsonization (GO:0008228) | 3.16999756 |
| 54 | aromatic amino acid family metabolic process (GO:0009072) | 3.16314762 |
| 55 | cellular modified amino acid catabolic process (GO:0042219) | 3.15213307 |
| 56 | imidazole-containing compound metabolic process (GO:0052803) | 3.15104876 |
| 57 | negative regulation of fibrinolysis (GO:0051918) | 3.13225797 |
| 58 | regulation of fibrinolysis (GO:0051917) | 3.11069667 |
| 59 | protein-lipid complex assembly (GO:0065005) | 3.10820174 |
| 60 | plasma lipoprotein particle clearance (GO:0034381) | 3.10042581 |
| 61 | protein-lipid complex subunit organization (GO:0071825) | 3.09354263 |
| 62 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.09045182 |
| 63 | ethanol oxidation (GO:0006069) | 3.07623062 |
| 64 | fatty acid beta-oxidation (GO:0006635) | 3.07145466 |
| 65 | negative regulation of cholesterol transport (GO:0032375) | 3.04111264 |
| 66 | negative regulation of sterol transport (GO:0032372) | 3.04111264 |
| 67 | alpha-amino acid catabolic process (GO:1901606) | 3.03712281 |
| 68 | cholesterol efflux (GO:0033344) | 3.03678809 |
| 69 | lipid oxidation (GO:0034440) | 3.02228604 |
| 70 | immunoglobulin mediated immune response (GO:0016064) | 3.01579541 |
| 71 | cholesterol catabolic process (GO:0006707) | 3.00710294 |
| 72 | sterol catabolic process (GO:0016127) | 3.00710294 |
| 73 | epoxygenase P450 pathway (GO:0019373) | 2.98817600 |
| 74 | short-chain fatty acid metabolic process (GO:0046459) | 2.98191825 |
| 75 | urea metabolic process (GO:0019627) | 2.95494845 |
| 76 | urea cycle (GO:0000050) | 2.95494845 |
| 77 | acylglycerol homeostasis (GO:0055090) | 2.93303690 |
| 78 | triglyceride homeostasis (GO:0070328) | 2.93303690 |
| 79 | fatty acid oxidation (GO:0019395) | 2.92966444 |
| 80 | amino-acid betaine metabolic process (GO:0006577) | 2.92694436 |
| 81 | cellular biogenic amine catabolic process (GO:0042402) | 2.92199050 |
| 82 | amine catabolic process (GO:0009310) | 2.92199050 |
| 83 | cellular amino acid catabolic process (GO:0009063) | 2.90622862 |
| 84 | fatty acid catabolic process (GO:0009062) | 2.90488315 |
| 85 | homocysteine metabolic process (GO:0050667) | 2.89516947 |
| 86 | cellular glucuronidation (GO:0052695) | 2.86601520 |
| 87 | monocarboxylic acid catabolic process (GO:0072329) | 2.85347253 |
| 88 | peptide catabolic process (GO:0043171) | 2.85280120 |
| 89 | exogenous drug catabolic process (GO:0042738) | 2.83870760 |
| 90 | indolalkylamine metabolic process (GO:0006586) | 2.81026023 |
| 91 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.80294539 |
| 92 | cellular ketone body metabolic process (GO:0046950) | 2.79717451 |
| 93 | cellular response to type I interferon (GO:0071357) | 2.79296453 |
| 94 | type I interferon signaling pathway (GO:0060337) | 2.79296453 |
| 95 | nitrogen cycle metabolic process (GO:0071941) | 2.79267138 |
| 96 | detection of external biotic stimulus (GO:0098581) | 2.78859324 |
| 97 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.78040257 |
| 98 | response to type I interferon (GO:0034340) | 2.77710432 |
| 99 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.77616637 |
| 100 | positive regulation of antigen processing and presentation (GO:0002579) | 2.77494516 |
| 101 | organic acid catabolic process (GO:0016054) | 2.74839877 |
| 102 | carboxylic acid catabolic process (GO:0046395) | 2.74839877 |
| 103 | bile acid and bile salt transport (GO:0015721) | 2.73880409 |
| 104 | phospholipid homeostasis (GO:0055091) | 2.72319233 |
| 105 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.71342229 |
| 106 | regulation of antigen processing and presentation (GO:0002577) | 2.71316543 |
| 107 | germinal center formation (GO:0002467) | 2.71240787 |
| 108 | cellular response to cholesterol (GO:0071397) | 2.70358490 |
| 109 | lipoprotein metabolic process (GO:0042157) | 2.69938132 |
| 110 | regulation of triglyceride metabolic process (GO:0090207) | 2.68927975 |
| 111 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.67962764 |
| 112 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.67962764 |
| 113 | regulation of cholesterol homeostasis (GO:2000188) | 2.67708165 |
| 114 | drug transmembrane transport (GO:0006855) | 2.67153182 |
| 115 | glutamate metabolic process (GO:0006536) | 2.66777037 |
| 116 | regulation of gamma-delta T cell activation (GO:0046643) | 2.65434889 |
| 117 | positive regulation of steroid metabolic process (GO:0045940) | 2.65163297 |
| 118 | serine family amino acid catabolic process (GO:0009071) | 2.64625080 |
| 119 | signal peptide processing (GO:0006465) | 2.63762065 |
| 120 | coenzyme catabolic process (GO:0009109) | 2.63400771 |
| 121 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.60075907 |
| 122 | positive regulation of type 2 immune response (GO:0002830) | 2.59676800 |
| 123 | drug catabolic process (GO:0042737) | 2.59307733 |
| 124 | macrophage activation involved in immune response (GO:0002281) | 2.57721180 |
| 125 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.55804683 |
| 126 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.55461883 |
| 127 | regulation of germinal center formation (GO:0002634) | 2.54233325 |
| 128 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.51251182 |
| 129 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.51251182 |
| 130 | modulation by symbiont of host immune response (GO:0052553) | 2.51251182 |
| 131 | positive regulation by symbiont of host defense response (GO:0052509) | 2.51251182 |
| 132 | modulation by symbiont of host defense response (GO:0052031) | 2.51251182 |
| 133 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.51251182 |
| 134 | negative regulation of innate immune response (GO:0045824) | 2.49041370 |
| 135 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.48829184 |
| 136 | response to peptidoglycan (GO:0032494) | 2.48606370 |
| 137 | negative regulation of humoral immune response (GO:0002921) | 2.47573742 |
| 138 | positive regulation of sterol transport (GO:0032373) | 2.45855810 |
| 139 | positive regulation of cholesterol transport (GO:0032376) | 2.45855810 |
| 140 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.44222901 |
| 141 | omega-hydroxylase P450 pathway (GO:0097267) | 2.43150064 |
| 142 | detection of biotic stimulus (GO:0009595) | 2.41911262 |
| 143 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.41237363 |
| 144 | neutrophil activation involved in immune response (GO:0002283) | 2.40071894 |
| 145 | T-helper 1 type immune response (GO:0042088) | 2.40062759 |
| 146 | detection of molecule of bacterial origin (GO:0032490) | 2.39716190 |
| 147 | positive thymic T cell selection (GO:0045059) | 2.39577995 |
| 148 | ethanol metabolic process (GO:0006067) | 2.39265994 |
| 149 | hormone catabolic process (GO:0042447) | 2.36708900 |
| 150 | adhesion of symbiont to host cell (GO:0044650) | 2.36020020 |
| 151 | virion attachment to host cell (GO:0019062) | 2.36020020 |
| 152 | regulation of macrophage chemotaxis (GO:0010758) | 2.35581505 |
| 153 | positive regulation of cholesterol efflux (GO:0010875) | 2.34864271 |
| 154 | regulation of type 2 immune response (GO:0002828) | 2.33947732 |
| 155 | negative regulation of interleukin-12 production (GO:0032695) | 2.33152142 |
| 156 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.32641562 |
| 157 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.32403948 |
| 158 | negative regulation of complement activation (GO:0045916) | 2.30651704 |
| 159 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.29389701 |
| 160 | B cell mediated immunity (GO:0019724) | 2.27949195 |
| 161 | urate metabolic process (GO:0046415) | 2.27405123 |
| 162 | regulation of tolerance induction (GO:0002643) | 2.27241007 |
| 163 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.26907338 |
| 164 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.25778242 |
| 165 | negative regulation of protein activation cascade (GO:2000258) | 2.25326722 |
| 166 | keratan sulfate catabolic process (GO:0042340) | 2.24639055 |
| 167 | response to muramyl dipeptide (GO:0032495) | 2.24135305 |
| 168 | positive regulation of macrophage cytokine production (GO:0060907) | 2.22494235 |
| 169 | regulation of humoral immune response (GO:0002920) | 2.21547852 |
| 170 | negative thymic T cell selection (GO:0045060) | 2.20379939 |
| 171 | regulation of macrophage cytokine production (GO:0010935) | 2.19776479 |
| 172 | positive regulation of B cell differentiation (GO:0045579) | 2.19358116 |
| 173 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.18579256 |
| 174 | amino sugar catabolic process (GO:0046348) | 2.16753903 |
| 175 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.16127201 |
| 176 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.15205728 |
| 177 | negative regulation of type 2 immune response (GO:0002829) | 2.14296154 |
| 178 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.14060578 |
| 179 | microglial cell activation (GO:0001774) | 2.14045795 |
| 180 | cellular response to interferon-gamma (GO:0071346) | 2.13314354 |
| 181 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.13236623 |
| 182 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.13029341 |
| 183 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.11687796 |
| 184 | positive regulation of tolerance induction (GO:0002645) | 2.09850599 |
| 185 | regulation of cellular extravasation (GO:0002691) | 2.09070086 |
| 186 | negative T cell selection (GO:0043383) | 2.09025262 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.38418912 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.30778574 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.71057271 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.63616088 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.57471070 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.32493884 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.47109512 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.40531772 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.39755758 |
| 10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.16635835 |
| 11 | GATA1_22025678_ChIP-Seq_K562_Human | 2.87729979 |
| 12 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.61934781 |
| 13 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.51987150 |
| 14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.41092778 |
| 15 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.29480646 |
| 16 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.26576908 |
| 17 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.25324503 |
| 18 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.17006450 |
| 19 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.96172060 |
| 20 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.94686332 |
| 21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.80504196 |
| 22 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.75411719 |
| 23 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.74629260 |
| 24 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.69445873 |
| 25 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66400865 |
| 26 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.66352320 |
| 27 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64031518 |
| 28 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.59291165 |
| 29 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.56412740 |
| 30 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.55170989 |
| 31 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.48032732 |
| 32 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.42300643 |
| 33 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.42062982 |
| 34 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.41165632 |
| 35 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.40588143 |
| 36 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.36135305 |
| 37 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.32789915 |
| 38 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.31124683 |
| 39 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.30267566 |
| 40 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.27804490 |
| 41 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.25188128 |
| 42 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22908061 |
| 43 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.17746389 |
| 44 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.13766628 |
| 45 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.13114086 |
| 46 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.12185852 |
| 47 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11663705 |
| 48 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.10741112 |
| 49 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.10725033 |
| 50 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.10718056 |
| 51 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.10480524 |
| 52 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.10414782 |
| 53 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.07290643 |
| 54 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.07197491 |
| 55 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.06959276 |
| 56 | GATA1_19941826_ChIP-Seq_K562_Human | 1.05957233 |
| 57 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.04205430 |
| 58 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.04170184 |
| 59 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.99339066 |
| 60 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.97421566 |
| 61 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.96158713 |
| 62 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.96158713 |
| 63 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.92343240 |
| 64 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.91414428 |
| 65 | CJUN_26792858_Chip-Seq_BT549_Human | 0.91409910 |
| 66 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.89530065 |
| 67 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.89449981 |
| 68 | GATA2_19941826_ChIP-Seq_K562_Human | 0.87982783 |
| 69 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.87793620 |
| 70 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.86489439 |
| 71 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.86194164 |
| 72 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85845987 |
| 73 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.85235526 |
| 74 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.84226546 |
| 75 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.84001603 |
| 76 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.83419112 |
| 77 | GATA3_26560356_Chip-Seq_TH2_Human | 0.83326845 |
| 78 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.82295222 |
| 79 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82224047 |
| 80 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.81779744 |
| 81 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.80708267 |
| 82 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.79753315 |
| 83 | MYB_26560356_Chip-Seq_TH2_Human | 0.79659751 |
| 84 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.79219102 |
| 85 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.79092516 |
| 86 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.78905543 |
| 87 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.78659507 |
| 88 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.78550996 |
| 89 | AR_20517297_ChIP-Seq_VCAP_Human | 0.77508778 |
| 90 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.76286444 |
| 91 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.76024157 |
| 92 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.76024157 |
| 93 | MYB_26560356_Chip-Seq_TH1_Human | 0.76014258 |
| 94 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.75526529 |
| 95 | MAF_26560356_Chip-Seq_TH1_Human | 0.75198903 |
| 96 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.74792643 |
| 97 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.74335834 |
| 98 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.73906164 |
| 99 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.73787638 |
| 100 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.73554453 |
| 101 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.73356643 |
| 102 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.73187818 |
| 103 | SPI1_23127762_ChIP-Seq_K562_Human | 0.72650774 |
| 104 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.72336485 |
| 105 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.71788630 |
| 106 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.71622292 |
| 107 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.69709562 |
| 108 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.68345674 |
| 109 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.68144800 |
| 110 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.68059608 |
| 111 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.67674274 |
| 112 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.67568795 |
| 113 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.67311382 |
| 114 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.67264016 |
| 115 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.66793586 |
| 116 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.66627249 |
| 117 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.65851820 |
| 118 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.65378643 |
| 119 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.65130100 |
| 120 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.63967909 |
| 121 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.63852537 |
| 122 | RXR_22108803_ChIP-Seq_LS180_Human | 0.63509048 |
| 123 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.63253010 |
| 124 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.63048681 |
| 125 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.62636236 |
| 126 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.61640908 |
| 127 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.60189678 |
| 128 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.59504822 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.42757233 |
| 2 | MP0005360_urolithiasis | 4.70289325 |
| 3 | MP0005365_abnormal_bile_salt | 4.08103552 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.92519681 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.39194321 |
| 6 | MP0009840_abnormal_foam_cell | 3.10778421 |
| 7 | MP0010329_abnormal_lipoprotein_level | 2.79651918 |
| 8 | MP0003252_abnormal_bile_duct | 2.66614861 |
| 9 | MP0003303_peritoneal_inflammation | 2.65196800 |
| 10 | MP0003195_calcinosis | 2.57482614 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 2.56031445 |
| 12 | MP0003191_abnormal_cellular_cholesterol | 2.53552223 |
| 13 | MP0002254_reproductive_system_inflammat | 2.41537459 |
| 14 | MP0001835_abnormal_antigen_presentation | 2.31065982 |
| 15 | MP0005332_abnormal_amino_acid | 2.24892575 |
| 16 | MP0003690_abnormal_glial_cell | 2.15051216 |
| 17 | MP0009278_abnormal_bone_marrow | 2.04870602 |
| 18 | MP0005671_abnormal_response_to | 1.96190303 |
| 19 | MP0005058_abnormal_lysosome_morphology | 1.92715798 |
| 20 | MP0002138_abnormal_hepatobiliary_system | 1.87283264 |
| 21 | MP0001666_abnormal_nutrient_absorption | 1.85825632 |
| 22 | MP0002118_abnormal_lipid_homeostasis | 1.84367350 |
| 23 | MP0000685_abnormal_immune_system | 1.82302115 |
| 24 | MP0003868_abnormal_feces_composition | 1.81909295 |
| 25 | MP0000609_abnormal_liver_physiology | 1.70668592 |
| 26 | MP0001853_heart_inflammation | 1.69524796 |
| 27 | MP0001958_emphysema | 1.67539005 |
| 28 | MP0005083_abnormal_biliary_tract | 1.60537375 |
| 29 | MP0003724_increased_susceptibility_to | 1.59184044 |
| 30 | MP0000465_gastrointestinal_hemorrhage | 1.59077893 |
| 31 | MP0002405_respiratory_system_inflammati | 1.59072819 |
| 32 | MP0001790_abnormal_immune_system | 1.57734089 |
| 33 | MP0005387_immune_system_phenotype | 1.57734089 |
| 34 | MP0009785_altered_susceptibility_to | 1.57035069 |
| 35 | MP0008438_abnormal_cutaneous_collagen | 1.56943654 |
| 36 | MP0000604_amyloidosis | 1.55408632 |
| 37 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.53473430 |
| 38 | MP0001545_abnormal_hematopoietic_system | 1.52313442 |
| 39 | MP0005397_hematopoietic_system_phenotyp | 1.52313442 |
| 40 | MP0003183_abnormal_peptide_metabolism | 1.51177684 |
| 41 | MP0002998_abnormal_bone_remodeling | 1.49263461 |
| 42 | MP0009764_decreased_sensitivity_to | 1.49028876 |
| 43 | MP0001800_abnormal_humoral_immune | 1.44334568 |
| 44 | MP0005275_abnormal_skin_tensile | 1.43721565 |
| 45 | MP0009643_abnormal_urine_homeostasis | 1.41920827 |
| 46 | MP0002419_abnormal_innate_immunity | 1.41177071 |
| 47 | MP0001764_abnormal_homeostasis | 1.40037135 |
| 48 | MP0005464_abnormal_platelet_physiology | 1.39178938 |
| 49 | MP0009333_abnormal_splenocyte_physiolog | 1.38718697 |
| 50 | MP0005025_abnormal_response_to | 1.38698250 |
| 51 | MP0008469_abnormal_protein_level | 1.36265141 |
| 52 | MP0004019_abnormal_vitamin_homeostasis | 1.34554645 |
| 53 | MP0005000_abnormal_immune_tolerance | 1.33130914 |
| 54 | MP0005319_abnormal_enzyme/_coenzyme | 1.32662428 |
| 55 | MP0005164_abnormal_response_to | 1.30465767 |
| 56 | MP0003186_abnormal_redox_activity | 1.29906180 |
| 57 | MP0003300_gastrointestinal_ulcer | 1.27136443 |
| 58 | MP0003172_abnormal_lysosome_physiology | 1.26030860 |
| 59 | MP0005166_decreased_susceptibility_to | 1.25933860 |
| 60 | MP0000681_abnormal_thyroid_gland | 1.25013275 |
| 61 | MP0006082_CNS_inflammation | 1.23435744 |
| 62 | MP0002723_abnormal_immune_serum | 1.21249748 |
| 63 | MP0006054_spinal_hemorrhage | 1.20863054 |
| 64 | MP0004883_abnormal_blood_vessel | 1.20634908 |
| 65 | MP0002452_abnormal_antigen_presenting | 1.17230313 |
| 66 | MP0003329_amyloid_beta_deposits | 1.16809131 |
| 67 | MP0002166_altered_tumor_susceptibility | 1.16245112 |
| 68 | MP0001851_eye_inflammation | 1.15661252 |
| 69 | MP0003075_altered_response_to | 1.14683962 |
| 70 | MP0000343_altered_response_to | 1.14155324 |
| 71 | MP0002876_abnormal_thyroid_physiology | 1.13062901 |
| 72 | MP0003828_pulmonary_edema | 1.12229860 |
| 73 | MP0000920_abnormal_myelination | 1.11763729 |
| 74 | MP0000249_abnormal_blood_vessel | 1.10991100 |
| 75 | MP0005390_skeleton_phenotype | 1.09038127 |
| 76 | MP0003436_decreased_susceptibility_to | 1.08231554 |
| 77 | MP0001542_abnormal_bone_strength | 1.08024039 |
| 78 | MP0009697_abnormal_copulation | 1.07105947 |
| 79 | MP0001845_abnormal_inflammatory_respons | 1.06139026 |
| 80 | MP0009763_increased_sensitivity_to | 1.04418379 |
| 81 | MP0002148_abnormal_hypersensitivity_rea | 1.03072912 |
| 82 | MP0002420_abnormal_adaptive_immunity | 1.02958998 |
| 83 | MP0002933_joint_inflammation | 1.00828533 |
| 84 | MP0001819_abnormal_immune_cell | 1.00593532 |
| 85 | MP0005503_abnormal_tendon_morphology | 0.97373459 |
| 86 | MP0008004_abnormal_stomach_pH | 0.97182834 |
| 87 | MP0003763_abnormal_thymus_physiology | 0.96793703 |
| 88 | MP0003866_abnormal_defecation | 0.94809147 |
| 89 | MP0002078_abnormal_glucose_homeostasis | 0.93814808 |
| 90 | MP0000858_altered_metastatic_potential | 0.93579354 |
| 91 | MP0005647_abnormal_sex_gland | 0.93020097 |
| 92 | MP0005167_abnormal_blood-brain_barrier | 0.91681083 |
| 93 | MP0003011_delayed_dark_adaptation | 0.91331324 |
| 94 | MP0009642_abnormal_blood_homeostasis | 0.90574148 |
| 95 | MP0010368_abnormal_lymphatic_system | 0.90014198 |
| 96 | MP0002971_abnormal_brown_adipose | 0.89923097 |
| 97 | MP0001873_stomach_inflammation | 0.89459295 |
| 98 | MP0005379_endocrine/exocrine_gland_phen | 0.89404024 |
| 99 | MP0005636_abnormal_mineral_homeostasis | 0.89140299 |
| 100 | MP0000598_abnormal_liver_morphology | 0.87801337 |
| 101 | MP0002909_abnormal_adrenal_gland | 0.87782348 |
| 102 | MP0002398_abnormal_bone_marrow | 0.87326911 |
| 103 | MP0004130_abnormal_muscle_cell | 0.86709307 |
| 104 | MP0005310_abnormal_salivary_gland | 0.85580583 |
| 105 | MP0005023_abnormal_wound_healing | 0.85367583 |
| 106 | MP0003448_altered_tumor_morphology | 0.84843224 |
| 107 | MP0002006_tumorigenesis | 0.84524928 |
| 108 | MP0003656_abnormal_erythrocyte_physiolo | 0.83478204 |
| 109 | MP0000639_abnormal_adrenal_gland | 0.82569544 |
| 110 | MP0003638_abnormal_response/metabolism_ | 0.82402074 |
| 111 | MP0005670_abnormal_white_adipose | 0.81839875 |
| 112 | MP0002009_preneoplasia | 0.81663102 |
| 113 | MP0009384_cardiac_valve_regurgitation | 0.81450707 |
| 114 | MP0003091_abnormal_cell_migration | 0.81243047 |
| 115 | MP0000689_abnormal_spleen_morphology | 0.80443969 |
| 116 | MP0005645_abnormal_hypothalamus_physiol | 0.79675205 |
| 117 | MP0003795_abnormal_bone_structure | 0.79040770 |
| 118 | MP0002928_abnormal_bile_duct | 0.78444387 |
| 119 | MP0004510_myositis | 0.77186802 |
| 120 | MP0002090_abnormal_vision | 0.77088617 |
| 121 | MP0005165_increased_susceptibility_to | 0.76848599 |
| 122 | MP0005646_abnormal_pituitary_gland | 0.76737106 |
| 123 | MP0005334_abnormal_fat_pad | 0.76349101 |
| 124 | MP0004043_abnormal_pH_regulation | 0.76187972 |
| 125 | MP0000716_abnormal_immune_system | 0.76052060 |
| 126 | MP0005084_abnormal_gallbladder_morpholo | 0.75607571 |
| 127 | MP0005535_abnormal_body_temperature | 0.75245079 |
| 128 | MP0003045_fibrosis | 0.74722145 |
| 129 | MP0004947_skin_inflammation | 0.74454487 |
| 130 | MP0003279_aneurysm | 0.74126207 |
| 131 | MP0000013_abnormal_adipose_tissue | 0.73899103 |
| 132 | MP0002136_abnormal_kidney_physiology | 0.73676124 |
| 133 | MP0005220_abnormal_exocrine_pancreas | 0.72190268 |
| 134 | MP0009765_abnormal_xenobiotic_induced | 0.70868581 |
| 135 | MP0002693_abnormal_pancreas_physiology | 0.70535188 |
| 136 | MP0010155_abnormal_intestine_physiology | 0.69550324 |
| 137 | MP0004147_increased_porphyrin_level | 0.68369655 |
| 138 | MP0001533_abnormal_skeleton_physiology | 0.68261069 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.84471685 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 4.97362984 |
| 3 | Xanthomatosis (HP:0000991) | 4.73026345 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 4.68890482 |
| 5 | Deep venous thrombosis (HP:0002625) | 4.40621453 |
| 6 | Hyperlipoproteinemia (HP:0010980) | 4.30802737 |
| 7 | Hypoglycemic coma (HP:0001325) | 4.01551405 |
| 8 | Complement deficiency (HP:0004431) | 3.89600588 |
| 9 | Myositis (HP:0100614) | 3.86753609 |
| 10 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.81852836 |
| 11 | Joint hemorrhage (HP:0005261) | 3.77695387 |
| 12 | Abnormality of glycolipid metabolism (HP:0010969) | 3.71250202 |
| 13 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.71250202 |
| 14 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.71250202 |
| 15 | Hypobetalipoproteinemia (HP:0003563) | 3.65914186 |
| 16 | Orchitis (HP:0100796) | 3.57506371 |
| 17 | Ketosis (HP:0001946) | 3.52116239 |
| 18 | Optic neuritis (HP:0100653) | 3.33071594 |
| 19 | Retrobulbar optic neuritis (HP:0100654) | 3.33071594 |
| 20 | Abnormality of the common coagulation pathway (HP:0010990) | 3.29881601 |
| 21 | Ketoacidosis (HP:0001993) | 3.29524488 |
| 22 | Systemic lupus erythematosus (HP:0002725) | 3.28976544 |
| 23 | Hyperammonemia (HP:0001987) | 3.24511410 |
| 24 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.16308263 |
| 25 | Hypoglycemic seizures (HP:0002173) | 3.16011691 |
| 26 | Abnormality of the intrinsic pathway (HP:0010989) | 3.13420557 |
| 27 | Hyperglycinuria (HP:0003108) | 3.08083777 |
| 28 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.98982381 |
| 29 | Abnormality of glycine metabolism (HP:0010895) | 2.98982381 |
| 30 | Abnormality of methionine metabolism (HP:0010901) | 2.97556529 |
| 31 | Hypolipoproteinemia (HP:0010981) | 2.97274544 |
| 32 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.97035814 |
| 33 | Vacuolated lymphocytes (HP:0001922) | 2.94030503 |
| 34 | Fat malabsorption (HP:0002630) | 2.92557437 |
| 35 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.88932756 |
| 36 | Pulmonary infiltrates (HP:0002113) | 2.88020773 |
| 37 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.87845276 |
| 38 | Epidermoid cyst (HP:0200040) | 2.86877989 |
| 39 | Generalized aminoaciduria (HP:0002909) | 2.84232717 |
| 40 | Recurrent abscess formation (HP:0002722) | 2.79194434 |
| 41 | Hypoalphalipoproteinemia (HP:0003233) | 2.79104014 |
| 42 | Hyperglycinemia (HP:0002154) | 2.76112764 |
| 43 | Dysostosis multiplex (HP:0000943) | 2.72304670 |
| 44 | Amyloidosis (HP:0011034) | 2.71534141 |
| 45 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.67449884 |
| 46 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.66965746 |
| 47 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.66900450 |
| 48 | Hypercholesterolemia (HP:0003124) | 2.63929909 |
| 49 | Abnormality of macrophages (HP:0004311) | 2.63825028 |
| 50 | Mitral stenosis (HP:0001718) | 2.61696645 |
| 51 | Abnormality of complement system (HP:0005339) | 2.60699068 |
| 52 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.58881593 |
| 53 | Gastrointestinal infarctions (HP:0005244) | 2.58867932 |
| 54 | Spondylolisthesis (HP:0003302) | 2.58301820 |
| 55 | Gingival bleeding (HP:0000225) | 2.57257423 |
| 56 | Hyperbilirubinemia (HP:0002904) | 2.55575739 |
| 57 | Late onset (HP:0003584) | 2.55388325 |
| 58 | Conjugated hyperbilirubinemia (HP:0002908) | 2.55385695 |
| 59 | Gastrointestinal stroma tumor (HP:0100723) | 2.54572046 |
| 60 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.54167471 |
| 61 | Hypoplasia of the thymus (HP:0000778) | 2.51756656 |
| 62 | Pustule (HP:0200039) | 2.51314728 |
| 63 | Agammaglobulinemia (HP:0004432) | 2.47032504 |
| 64 | Glomerulonephritis (HP:0000099) | 2.46334556 |
| 65 | Hemoptysis (HP:0002105) | 2.45267251 |
| 66 | Chronic otitis media (HP:0000389) | 2.43538789 |
| 67 | Meningitis (HP:0001287) | 2.43470789 |
| 68 | Keratoconjunctivitis sicca (HP:0001097) | 2.42250867 |
| 69 | Delayed CNS myelination (HP:0002188) | 2.42030913 |
| 70 | Symptomatic seizures (HP:0011145) | 2.41457840 |
| 71 | Increased cerebral lipofuscin (HP:0011813) | 2.38659531 |
| 72 | Recurrent bronchitis (HP:0002837) | 2.38206839 |
| 73 | Nephritis (HP:0000123) | 2.34800382 |
| 74 | Gingivitis (HP:0000230) | 2.33692778 |
| 75 | Purpura (HP:0000979) | 2.33062849 |
| 76 | Myocardial infarction (HP:0001658) | 2.32597492 |
| 77 | Steatorrhea (HP:0002570) | 2.32394667 |
| 78 | Dicarboxylic aciduria (HP:0003215) | 2.31805180 |
| 79 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.31805180 |
| 80 | Asymmetric septal hypertrophy (HP:0001670) | 2.30227144 |
| 81 | Interstitial pulmonary disease (HP:0006530) | 2.29813810 |
| 82 | Neurofibrillary tangles (HP:0002185) | 2.29608174 |
| 83 | Keratoconjunctivitis (HP:0001096) | 2.28277592 |
| 84 | Arterial thrombosis (HP:0004420) | 2.28252252 |
| 85 | Progressive neurologic deterioration (HP:0002344) | 2.27683698 |
| 86 | Recurrent skin infections (HP:0001581) | 2.26041959 |
| 87 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.25302604 |
| 88 | Mucopolysacchariduria (HP:0008155) | 2.24695317 |
| 89 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.24695317 |
| 90 | Mediastinal lymphadenopathy (HP:0100721) | 2.21887724 |
| 91 | Sensorimotor neuropathy (HP:0007141) | 2.19351954 |
| 92 | Inflammation of the large intestine (HP:0002037) | 2.17712130 |
| 93 | Aortic dissection (HP:0002647) | 2.17062395 |
| 94 | Malnutrition (HP:0004395) | 2.13078726 |
| 95 | Premature loss of primary teeth (HP:0006323) | 2.12500211 |
| 96 | Recurrent sinusitis (HP:0011108) | 2.11178649 |
| 97 | Recurrent fungal infections (HP:0002841) | 2.11105190 |
| 98 | Elevated hepatic transaminases (HP:0002910) | 2.10588658 |
| 99 | Urticaria (HP:0001025) | 2.09794435 |
| 100 | Encephalitis (HP:0002383) | 2.07647727 |
| 101 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.06214440 |
| 102 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.06214440 |
| 103 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.06214440 |
| 104 | Gangrene (HP:0100758) | 2.04231280 |
| 105 | Joint swelling (HP:0001386) | 2.04201718 |
| 106 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.04147568 |
| 107 | Metaphyseal dysplasia (HP:0100255) | 2.02609722 |
| 108 | Gastrointestinal inflammation (HP:0004386) | 2.01362100 |
| 109 | Pancreatitis (HP:0001733) | 2.00168514 |
| 110 | Stomatitis (HP:0010280) | 1.99764373 |
| 111 | Increased IgE level (HP:0003212) | 1.97833878 |
| 112 | Peritonitis (HP:0002586) | 1.97462724 |
| 113 | Abnormality of T cell number (HP:0011839) | 1.96911885 |
| 114 | Hypergammaglobulinemia (HP:0010702) | 1.96657393 |
| 115 | T lymphocytopenia (HP:0005403) | 1.94746365 |
| 116 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.94609383 |
| 117 | Menorrhagia (HP:0000132) | 1.94600476 |
| 118 | Chronic diarrhea (HP:0002028) | 1.93935234 |
| 119 | Abnormality of serum amino acid levels (HP:0003112) | 1.93713290 |
| 120 | Hematochezia (HP:0002573) | 1.93687257 |
| 121 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.93588621 |
| 122 | Osteolytic defects of the hand bones (HP:0009699) | 1.93588621 |
| 123 | Protrusio acetabuli (HP:0003179) | 1.92004084 |
| 124 | Recurrent cutaneous fungal infections (HP:0011370) | 1.91536186 |
| 125 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.91536186 |
| 126 | Metabolic acidosis (HP:0001942) | 1.90551087 |
| 127 | Vertebral compression fractures (HP:0002953) | 1.90351592 |
| 128 | Abnormality of purine metabolism (HP:0004352) | 1.90082474 |
| 129 | Epistaxis (HP:0000421) | 1.89916807 |
| 130 | Striae distensae (HP:0001065) | 1.89149918 |
| 131 | Abnormality of the prostate (HP:0008775) | 1.89145755 |
| 132 | Spontaneous hematomas (HP:0007420) | 1.87973743 |
| 133 | Spontaneous abortion (HP:0005268) | 1.87189339 |
| 134 | Loss of speech (HP:0002371) | 1.87107618 |
| 135 | Acne (HP:0001061) | 1.86769289 |
| 136 | Chest pain (HP:0100749) | 1.86090668 |
| 137 | Joint stiffness (HP:0001387) | 1.85990646 |
| 138 | Pulmonary embolism (HP:0002204) | 1.85175853 |
| 139 | Cellulitis (HP:0100658) | 1.84789293 |
| 140 | Recurrent bacterial skin infections (HP:0005406) | 1.84405157 |
| 141 | Abnormality of the pleura (HP:0002103) | 1.84257134 |
| 142 | Obstructive lung disease (HP:0006536) | 1.84000457 |
| 143 | Chronic obstructive pulmonary disease (HP:0006510) | 1.84000457 |
| 144 | Irritability (HP:0000737) | 1.83505205 |
| 145 | Renal cortical cysts (HP:0000803) | 1.82542453 |
| 146 | Abnormality of secondary sexual hair (HP:0009888) | 1.82203912 |
| 147 | Abnormality of the axillary hair (HP:0100134) | 1.82203912 |
| 148 | Cervical subluxation (HP:0003308) | 1.81743739 |
| 149 | Paraparesis (HP:0002385) | 1.81506067 |
| 150 | Vascular tortuosity (HP:0004948) | 1.81425027 |
| 151 | IgM deficiency (HP:0002850) | 1.80170518 |
| 152 | Vascular calcification (HP:0004934) | 1.80086878 |
| 153 | Hemorrhage of the eye (HP:0011885) | 1.79930265 |
| 154 | Colitis (HP:0002583) | 1.79692936 |
| 155 | Enlarged kidneys (HP:0000105) | 1.78964511 |
| 156 | Leukocytosis (HP:0001974) | 1.76361463 |
| 157 | Xerostomia (HP:0000217) | 1.76033687 |
| 158 | Lethargy (HP:0001254) | 1.75889455 |
| 159 | Increased IgM level (HP:0003496) | 1.75121869 |
| 160 | Thrombophlebitis (HP:0004418) | 1.74736139 |
| 161 | Abnormality of nucleobase metabolism (HP:0010932) | 1.74550625 |
| 162 | Eczematoid dermatitis (HP:0000976) | 1.74092049 |
| 163 | Vasculitis (HP:0002633) | 1.73847735 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 3.30814284 |
| 2 | BCKDK | 3.12827630 |
| 3 | MAP4K1 | 2.79833169 |
| 4 | FGFR4 | 2.70635652 |
| 5 | SIK1 | 2.56965820 |
| 6 | INSRR | 2.49101640 |
| 7 | TIE1 | 2.44453215 |
| 8 | TYK2 | 2.41829704 |
| 9 | MAPK15 | 2.36908634 |
| 10 | KIT | 2.35860357 |
| 11 | TAOK3 | 2.33160760 |
| 12 | TNIK | 2.30028829 |
| 13 | IRAK3 | 2.21708060 |
| 14 | KDR | 2.13618176 |
| 15 | MAP3K14 | 2.08960742 |
| 16 | RIPK4 | 2.08541826 |
| 17 | TBK1 | 1.92390286 |
| 18 | EPHB1 | 1.91353563 |
| 19 | TGFBR2 | 1.90129301 |
| 20 | CSF1R | 1.81833877 |
| 21 | IKBKE | 1.79272562 |
| 22 | IRAK4 | 1.73441201 |
| 23 | BLK | 1.72714661 |
| 24 | JAK3 | 1.72209957 |
| 25 | FLT3 | 1.65561823 |
| 26 | JAK1 | 1.63179888 |
| 27 | PIK3CG | 1.57249925 |
| 28 | TEC | 1.55494325 |
| 29 | NEK9 | 1.51383237 |
| 30 | RIPK1 | 1.50075719 |
| 31 | BTK | 1.46812008 |
| 32 | PRPF4B | 1.42020263 |
| 33 | MUSK | 1.41169180 |
| 34 | NLK | 1.38875013 |
| 35 | TXK | 1.34820593 |
| 36 | IRAK1 | 1.33030509 |
| 37 | ZAP70 | 1.32145622 |
| 38 | MAP3K13 | 1.22025300 |
| 39 | SYK | 1.19512664 |
| 40 | GRK7 | 1.15778891 |
| 41 | ITK | 1.12999682 |
| 42 | BMPR1B | 1.08571926 |
| 43 | LYN | 1.07305157 |
| 44 | MAPK11 | 1.04987424 |
| 45 | LMTK2 | 1.00773974 |
| 46 | CSK | 0.99699426 |
| 47 | PRKCQ | 0.98294409 |
| 48 | DDR2 | 0.97696964 |
| 49 | FGFR3 | 0.96835402 |
| 50 | MAP3K3 | 0.96509860 |
| 51 | EPHA3 | 0.93735734 |
| 52 | JAK2 | 0.91430081 |
| 53 | CDC42BPA | 0.91033513 |
| 54 | ACVR1B | 0.90880200 |
| 55 | FGFR2 | 0.87921303 |
| 56 | LCK | 0.85284162 |
| 57 | IRAK2 | 0.83694423 |
| 58 | GRK1 | 0.82831293 |
| 59 | FRK | 0.82293660 |
| 60 | HIPK2 | 0.77668466 |
| 61 | FER | 0.74632722 |
| 62 | PRKCH | 0.73606567 |
| 63 | IGF1R | 0.72842581 |
| 64 | MAPK12 | 0.72057455 |
| 65 | MOS | 0.71438618 |
| 66 | SCYL2 | 0.70693394 |
| 67 | HCK | 0.70376441 |
| 68 | PDGFRB | 0.69904169 |
| 69 | FES | 0.69797826 |
| 70 | MAP4K2 | 0.69481284 |
| 71 | IKBKB | 0.68343757 |
| 72 | GRK6 | 0.67373652 |
| 73 | NME2 | 0.67045676 |
| 74 | DYRK1B | 0.67039841 |
| 75 | PRKG2 | 0.66995539 |
| 76 | CAMKK2 | 0.66317630 |
| 77 | PTK6 | 0.65209468 |
| 78 | PDGFRA | 0.64203837 |
| 79 | MAPK7 | 0.62753990 |
| 80 | MAP3K11 | 0.61938154 |
| 81 | PRKAA2 | 0.60476884 |
| 82 | TGFBR1 | 0.59721171 |
| 83 | MAP3K1 | 0.58147255 |
| 84 | MAP3K2 | 0.57549127 |
| 85 | PHKG1 | 0.57306191 |
| 86 | PHKG2 | 0.57306191 |
| 87 | TNK2 | 0.55167853 |
| 88 | MAP2K2 | 0.54001515 |
| 89 | CDK6 | 0.52532805 |
| 90 | PRKD1 | 0.51822377 |
| 91 | TRPM7 | 0.51717562 |
| 92 | DMPK | 0.51350188 |
| 93 | GRK5 | 0.51317720 |
| 94 | CHUK | 0.50964158 |
| 95 | MAP2K3 | 0.49244696 |
| 96 | FGR | 0.48895388 |
| 97 | OXSR1 | 0.48770608 |
| 98 | PRKD2 | 0.47368309 |
| 99 | LRRK2 | 0.47336073 |
| 100 | CSNK1G1 | 0.46595674 |
| 101 | CDK3 | 0.46574600 |
| 102 | STK16 | 0.46502100 |
| 103 | MATK | 0.46285304 |
| 104 | CAMK1D | 0.45653434 |
| 105 | MAPK4 | 0.45297975 |
| 106 | NUAK1 | 0.45204628 |
| 107 | PIK3CA | 0.45023349 |
| 108 | PKN1 | 0.44588667 |
| 109 | MAP3K7 | 0.43970220 |
| 110 | ERBB4 | 0.43935488 |
| 111 | STK39 | 0.43590355 |
| 112 | YES1 | 0.43316559 |
| 113 | PRKCD | 0.42982158 |
| 114 | CAMKK1 | 0.41957795 |
| 115 | MAPKAPK5 | 0.41901769 |
| 116 | MAPKAPK2 | 0.41660159 |
| 117 | PDK1 | 0.40605778 |
| 118 | MAP2K6 | 0.40137218 |
| 119 | ADRBK2 | 0.39039843 |
| 120 | TRIB3 | 0.38597533 |
| 121 | MAP3K6 | 0.38176254 |
| 122 | MST4 | 0.38149105 |
| 123 | ABL1 | 0.38017090 |
| 124 | MET | 0.37498314 |
| 125 | RET | 0.37298170 |
| 126 | PRKACG | 0.37067697 |
| 127 | MYLK | 0.36442455 |
| 128 | PAK2 | 0.34968263 |
| 129 | PDPK1 | 0.34905452 |
| 130 | PINK1 | 0.34621924 |
| 131 | MARK2 | 0.34201200 |
| 132 | FYN | 0.33432049 |
| 133 | BMPR2 | 0.32711948 |
| 134 | CAMK2G | 0.31975959 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.02578611 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.74682272 |
| 3 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.77356920 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.75207913 |
| 5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.55298263 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.52508015 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.50502796 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.50339165 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.46186016 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.40181267 |
| 11 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.38122663 |
| 12 | Peroxisome_Homo sapiens_hsa04146 | 2.28836855 |
| 13 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.27333726 |
| 14 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.20331307 |
| 15 | Asthma_Homo sapiens_hsa05310 | 2.18873973 |
| 16 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.05555825 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 2.00380708 |
| 18 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.99950009 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.99813075 |
| 20 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.99534283 |
| 21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.98167217 |
| 22 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.96526337 |
| 23 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.94282928 |
| 24 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.91840145 |
| 25 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.91395490 |
| 26 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.91162337 |
| 27 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.90290669 |
| 28 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.78678262 |
| 29 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.77561768 |
| 30 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.75610596 |
| 31 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.69458748 |
| 32 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.62041687 |
| 33 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.60224738 |
| 34 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.57934247 |
| 35 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.56014652 |
| 36 | ABC transporters_Homo sapiens_hsa02010 | 1.54855149 |
| 37 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.46150988 |
| 38 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.44041249 |
| 39 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.42264218 |
| 40 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.39848653 |
| 41 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.32140663 |
| 42 | Tuberculosis_Homo sapiens_hsa05152 | 1.26255925 |
| 43 | Viral myocarditis_Homo sapiens_hsa05416 | 1.23214775 |
| 44 | Retinol metabolism_Homo sapiens_hsa00830 | 1.22510669 |
| 45 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.21587803 |
| 46 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.20527291 |
| 47 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.20495641 |
| 48 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.20223783 |
| 49 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.18321583 |
| 50 | Bile secretion_Homo sapiens_hsa04976 | 1.17498555 |
| 51 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.17092460 |
| 52 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.12243630 |
| 53 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.11426240 |
| 54 | Other glycan degradation_Homo sapiens_hsa00511 | 1.09462263 |
| 55 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.04832142 |
| 56 | Protein export_Homo sapiens_hsa03060 | 1.03537387 |
| 57 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.02846762 |
| 58 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.02805984 |
| 59 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.01009505 |
| 60 | Influenza A_Homo sapiens_hsa05164 | 0.96620590 |
| 61 | Phagosome_Homo sapiens_hsa04145 | 0.92256851 |
| 62 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.92073238 |
| 63 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.91487085 |
| 64 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.91022355 |
| 65 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.89215658 |
| 66 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.89107020 |
| 67 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.87588722 |
| 68 | * Lysosome_Homo sapiens_hsa04142 | 0.87202433 |
| 69 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.86837942 |
| 70 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.86409684 |
| 71 | Sulfur relay system_Homo sapiens_hsa04122 | 0.85531331 |
| 72 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.84622190 |
| 73 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.83230916 |
| 74 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.78828393 |
| 75 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.78508517 |
| 76 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.76359420 |
| 77 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.75996578 |
| 78 | Hepatitis C_Homo sapiens_hsa05160 | 0.75130536 |
| 79 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.71990471 |
| 80 | Amoebiasis_Homo sapiens_hsa05146 | 0.70826597 |
| 81 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.70135946 |
| 82 | Platelet activation_Homo sapiens_hsa04611 | 0.69979229 |
| 83 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.69521876 |
| 84 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.69446554 |
| 85 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.67858834 |
| 86 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.65949466 |
| 87 | Legionellosis_Homo sapiens_hsa05134 | 0.58480896 |
| 88 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.58093436 |
| 89 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.57997175 |
| 90 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.56511789 |
| 91 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.56088366 |
| 92 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.55782058 |
| 93 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.55468741 |
| 94 | Carbon metabolism_Homo sapiens_hsa01200 | 0.54796562 |
| 95 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.53125045 |
| 96 | Malaria_Homo sapiens_hsa05144 | 0.52431244 |
| 97 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.51006185 |
| 98 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.50155858 |
| 99 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.49855663 |
| 100 | Mineral absorption_Homo sapiens_hsa04978 | 0.48249114 |
| 101 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.47644831 |
| 102 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.45951991 |
| 103 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.45946707 |
| 104 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.45454680 |
| 105 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.45318522 |
| 106 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.44419320 |
| 107 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.44349391 |
| 108 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.43751559 |
| 109 | Prion diseases_Homo sapiens_hsa05020 | 0.42517656 |
| 110 | Renin secretion_Homo sapiens_hsa04924 | 0.41284395 |
| 111 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.40848789 |
| 112 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.40325172 |
| 113 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.39710063 |
| 114 | Metabolic pathways_Homo sapiens_hsa01100 | 0.39313194 |
| 115 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.38816475 |
| 116 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.35992692 |
| 117 | Hepatitis B_Homo sapiens_hsa05161 | 0.35908811 |
| 118 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.35525760 |
| 119 | Lysine degradation_Homo sapiens_hsa00310 | 0.35496855 |
| 120 | Insulin resistance_Homo sapiens_hsa04931 | 0.35411131 |
| 121 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.33732020 |
| 122 | Salmonella infection_Homo sapiens_hsa05132 | 0.32770752 |
| 123 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.32225957 |
| 124 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.30516273 |
| 125 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.30344849 |
| 126 | Leishmaniasis_Homo sapiens_hsa05140 | 0.30255217 |
| 127 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.29375653 |
| 128 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.28931330 |
| 129 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.28553823 |
| 130 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.26839821 |
| 131 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.25693111 |
| 132 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.25643642 |
| 133 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.24581402 |
| 134 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.24317948 |
| 135 | Galactose metabolism_Homo sapiens_hsa00052 | 0.23273383 |
| 136 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.22946623 |
| 137 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.22675289 |
| 138 | Pertussis_Homo sapiens_hsa05133 | 0.22332225 |
| 139 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.22276392 |
| 140 | Measles_Homo sapiens_hsa05162 | 0.18268593 |
| 141 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.16916964 |
| 142 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.15252087 |

